C08.0
Malignant neoplasm of submandibular gland
Clinical Classification Guidelines
Inclusion Terms
- Malignant neoplasm of submaxillary gland
Medical Intelligence & Overview
Malignant neoplasm of the submandibular gland, classified under ICD-10 code C08.0, refers to a type of cancer that originates in the submandibular gland, one of the major salivary glands located beneath the lower jaw. This condition is also known as a malignant tumor of the submaxillary gland and can impact the function and health of the affected individual. Recognizing the characteristics, causes, symptoms, and treatment options associated with this disease is essential for early diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic factors that may predispose individuals to salivary gland cancers. Radiation exposure, especially to the head and neck area. Chronic inflammation or persistent infections of the salivary glands. History of prior cancer or certain syndromes increasing cancer risk. Environmental exposures to carcinogens such as certain chemicals and toxins. Age-related factors, often appearing in middle-aged and older adults. Gender-related risks, with some studies suggesting slight variations between males and females.
Key Symptoms: A noticeable lump or swelling beneath the jaw or in the area of the affected gland. Pain or discomfort in the jaw, face, or neck region. Numbness or weakness in facial muscles, indicating nerve involvement. Difficulty swallowing or opening the mouth fully. Persistent or unexplained facial pain. Loss of taste or altered taste sensations. Unexplained weight loss or general fatigue in advanced cases. Changes in the firmness or texture of the affected gland.
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess the size, consistency, and mobility of the lump. Imaging studies such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) to visualize the tumor and evaluate spread. Fine needle aspiration biopsy (FNAB) or tissue biopsy to confirm malignancy and determine histological type. Blood tests to assess overall health and look for markers associated with cancer. Assessment of potential metastasis through additional imaging if necessary.
Treatment Protocols: Surgical removal of the affected submandibular gland, often combined with removal of nearby lymph nodes if spread is suspected. Radiation therapy, either post-surgery or as a primary treatment when surgery isn't feasible, to target remaining cancerous cells. Chemotherapy, although its role in salivary gland cancers is limited and usually considered in advanced or metastatic cases. Targeted therapy or immunotherapy in certain cases where specific genetic markers are identified. Supportive and palliative care to manage symptoms and improve quality of life in advanced disease stages.
Clinical Advice & FAQs
Billing Guidance
Is C08.0 a billable ICD-10 code?
Yes, C08.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C08.0?
Clinical documentation must specify the nature of Malignant neoplasm of submandibular gland and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
